
PMC:7033706 / 5285-5511
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"102","span":{"begin":152,"end":156},"obj":"Gene"},{"id":"103","span":{"begin":16,"end":17},"obj":"Gene"},{"id":"115","span":{"begin":6,"end":15},"obj":"Species"},{"id":"116","span":{"begin":60,"end":68},"obj":"Species"},{"id":"119","span":{"begin":206,"end":225},"obj":"Disease"}],"attributes":[{"id":"A102","pred":"tao:has_database_id","subj":"102","obj":"Gene:6941"},{"id":"A103","pred":"tao:has_database_id","subj":"103","obj":"Gene:43740568"},{"id":"A115","pred":"tao:has_database_id","subj":"115","obj":"Tax:2697049"},{"id":"A116","pred":"tao:has_database_id","subj":"116","obj":"Tax:694009"},{"id":"A119","pred":"tao:has_database_id","subj":"119","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Since 2019-nCoV S-HR2 sequence is 100% identical to that of SARS-CoV, while there are only a few mutations of non-critical amino acids in S-HR1 region, SC-1 peptide is expected to be also effective against 2019-nCoV infection."}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T19","span":{"begin":123,"end":134},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma82739"}],"text":"Since 2019-nCoV S-HR2 sequence is 100% identical to that of SARS-CoV, while there are only a few mutations of non-critical amino acids in S-HR1 region, SC-1 peptide is expected to be also effective against 2019-nCoV infection."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":60,"end":68},"obj":"Disease"},{"id":"T18","span":{"begin":206,"end":225},"obj":"Disease"},{"id":"T19","span":{"begin":216,"end":225},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Since 2019-nCoV S-HR2 sequence is 100% identical to that of SARS-CoV, while there are only a few mutations of non-critical amino acids in S-HR1 region, SC-1 peptide is expected to be also effective against 2019-nCoV infection."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T71","span":{"begin":91,"end":92},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T72","span":{"begin":152,"end":156},"obj":"http://purl.obolibrary.org/obo/CLO_0008956"},{"id":"T73","span":{"begin":152,"end":156},"obj":"http://purl.obolibrary.org/obo/CLO_0008957"},{"id":"T74","span":{"begin":152,"end":156},"obj":"http://purl.obolibrary.org/obo/CLO_0008958"},{"id":"T75","span":{"begin":152,"end":156},"obj":"http://purl.obolibrary.org/obo/CLO_0050606"},{"id":"T76","span":{"begin":157,"end":164},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"Since 2019-nCoV S-HR2 sequence is 100% identical to that of SARS-CoV, while there are only a few mutations of non-critical amino acids in S-HR1 region, SC-1 peptide is expected to be also effective against 2019-nCoV infection."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T33","span":{"begin":123,"end":134},"obj":"Chemical"},{"id":"T34","span":{"begin":123,"end":128},"obj":"Chemical"},{"id":"T35","span":{"begin":129,"end":134},"obj":"Chemical"},{"id":"T36","span":{"begin":152,"end":156},"obj":"Chemical"},{"id":"T37","span":{"begin":157,"end":164},"obj":"Chemical"}],"attributes":[{"id":"A33","pred":"chebi_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/CHEBI_33709"},{"id":"A34","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_46882"},{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A36","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_136542"},{"id":"A37","pred":"chebi_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"Since 2019-nCoV S-HR2 sequence is 100% identical to that of SARS-CoV, while there are only a few mutations of non-critical amino acids in S-HR1 region, SC-1 peptide is expected to be also effective against 2019-nCoV infection."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T30","span":{"begin":0,"end":226},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Since 2019-nCoV S-HR2 sequence is 100% identical to that of SARS-CoV, while there are only a few mutations of non-critical amino acids in S-HR1 region, SC-1 peptide is expected to be also effective against 2019-nCoV infection."}